OSMT Osmotica Pharmaceuticals plc

3
+0.11  (+4%)
Previous Close 2.89
Open 2.89
Price To Book 0.61
Market Cap 157,556,772
Shares 52,518,924
Volume 241,064
Short Ratio
Av. Daily Volume 103,526

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

NDA filing due 3Q 2019.
RVL-1201
Blepharoptosis
Phase 3 data March 27, 2019 noted one of two endpoints met.
Ontinua ER
Spasticity resulting from multiple sclerosis

Latest News

  1. Osmotica Pharmaceuticals plc Reports Second Quarter 2019 Results
  2. Osmotica Pharmaceuticals plc to Provide Second Quarter 2019 Business and Financial Update on August 8, 2019
  3. Shareholder Rights Law Firm Johnson Fistel Launches Investigations
  4. Osmotica Pharmaceuticals plc to Present at Jefferies 2019 Global Healthcare Conference
  5. Breakeven On The Horizon For Osmotica Pharmaceuticals plc (NASDAQ:OSMT)
  6. Osmotica Pharmaceuticals plc to Present at 2019 RBC Capital Markets Global Healthcare Conference
  7. Osmotica Pharmaceuticals plc Reports First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress
  8. The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex
  9. Osmotica Pharmaceuticals plc Announces Positive Topline Results of Phase III Clinical Trials of RVL-1201 (“RVL”) for Acquired Blepharoptosis (ptosis or droopy eyelid)
  10. Osmotica Pharmaceuticals plc to Provide First Quarter 2019 Business and Financial Update on May 9, 2019
  11. Robbins Arroyo LLP is Investigating the Officers and Directors of Osmotica Pharmaceuticals plc (OSMT) on Behalf of Shareholders
  12. INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Osmotica Pharmaceuticals plc Investors
  13. Glancy Prongay & Murray LLP Announces Investigation on Behalf of Osmotica Pharmaceuticals plc Investors (OSMT)
  14. Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., iRhythm Technologies, Inc., Orion Group Holdings, Inc., Osmotica Pharmaceuticals plc, Quantenna Communications, Inc., WABCO Holdings, Inc. and Zafgen, Inc.
  15. The Daily Biotech Pulse: Safety Board Clears Eisai's Alzheimer's Study, Positive Trial Results For Galapagos-Gilead
  16. SHAREHOLDER ALERT: Investigation of Osmotica Announced by Holzer & Holzer, LLC
  17. Osmotica Pharmaceuticals plc Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress
  18. Health Care Stocks Are Big Winners for an Aging Population